Antimicrobial activity of cefazolin-impregnated mesh grafts

ANZ Journal of Surgery

Volumn 77, Issue 4, 2007, Pages 256-260

  Kilic, Dilek ^a,c   Agalar, Canan ^a   Ozturk, Eylem ^b   Denkbas, Emir B ^b   Cime, Abdullah ^a   Agalar, Fatih ^a  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

Antimicrobial activity; Cefazolin impregnation; Cefazolin release; Mesh graft

Indexed keywords

CEFAZOLIN; POLYGLACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEVICE; DRUG EFFICACY; DRUG RELEASE; MALE; NONHUMAN; PLANT GRAFTING; RAT; SLOW RELEASE FORMULATION;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CEFAZOLIN; DRUG DELIVERY SYSTEMS; MALE; MICROBIAL SENSITIVITY TESTS; RATS; RATS, WISTAR; STATISTICS, NONPARAMETRIC; SURGICAL MESH;

EID: 33947136885     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2007.04029.x     Document Type: Article

References (23)

1. Junge K, Rosch R, Klinge U et al. Gentamicin supplementation of polyvinylidenfluoride mesh materials for infection prophylaxis. Biomaterials 2005; 26: 787-93.
2. Junge K, Klinge U, Klosterhalfen B, Rosch R, Stumpf M, Schumpelick V. Foreign body reaction to meshes used for the repair of abdominal wall hernias. Eur. J. Surg. 1999; 165: 665-73.
3. Gaonkar TA, Sampath LA, Modak SM. Evaluation of the antimicrobial efficacy of urinary catheters impregnated with antiseptics in an in vitro urinary tract model. Infect. Control Hosp. Epidemiol. 2003; 24: 506-13.
4. Alexander JW, Kaplan JZ, Altemeier WA. Role of suture materials in the development of wound infection. Ann. Surg. 1967; 165: 192-9.
5. Giacometti A, Cirioni O, Ghiselli R et al. Efficacy of quinupristin-dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. Antimicrob. Agents Chemother. 2002; 46: 2885-8.
6. Dunne WM Jr, Mason EO Jr, Kaplan SL. Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob. Agents Chemother. 1993; 37: 2522-6.
7. Troy MG, Dong QS, Dobrin PB, Hecht D. Do topical antibiotics provide improved prophylaxis against bacterial growth in the presence of polypropylene mesh? Am. J. Surg. 1996; 171: 391-3.
8. Darouiche RO, Fowler VG Jr, Adal K, Kielhofner M, Mansouri D, Reller LB. Antimicrobial activity of prosthetic heart valve sewing cuffs coated with minocycline and rifampin. Antimicrob. Agents Chemother. 2002; 46: 543-5.
9. Citak MS, Cue JI, Peyton JC, Malangoni MA. The critical relationship of antibiotic dose and bacterial contamination in experimental infection. J. Surg. Res. 1992; 52: 127-30.
10. Darouiche RO, Raad II, Heard SO et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N. Engl. J. Med. 1999; 340: 1-8.
11. Bandyk DF. Antibiotics - why so many and when should we use them? Semin. Vasc. Surg. 2002; 15: 268-74.
12. Kim CY, Kumar A, Sampath L, Sokol K, Modak S. Evaluation of an antimicrobial-impregnated continuous ambulatory peritoneal dialysis catheter for infection control in rats. Am. J. Kidney Dis. 2002; 39: 165-73.
13. Liedberg H, Lundeberg T. Silver alloy coated catheters reduce catheter-associated bacteriuria. Br. J. Urol. 1990; 65: 379-81.
14. Webster J, Hood RH, Burridge CA, Doidge ML, Phillips KM, George N. Water or antiseptic for periurethral cleaning before urinary catheterization: a randomized controlled trial. Am. J. Infect. Control 2001; 29: 389-94.
15. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 5th edn. Wayne, PA: National Committee for Clinical Laboratory Standards; Approved standard M7-A5, 2004.
16. Henke PK, Bergamini TM, Rose SM, Richardson JD. Current options in prosthetic vascular graft infection. Am. Surg. 1998; 64: 39-45.
17. Woodford N, Johnson AP, Morrison D, Speller DC. Current perspectives on glycopeptide resistance. Clin. Microbiol. Rev. 1995; 8: 585-615.
18. McManus AT, Goodwin CW, Pruitt BA Jr. Observations on the risk of resistance with the extended use of vancomycin. Arch. Surg. 1998; 133: 1207-11.
19. Raad I, Hachem R, Tcholakian RK, Sherertz R. Efficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits. Antimicrob. Agents Chemother. 2002; 46: 327-32.
20. Obst G, Gagnon RF, Haris J, Prentis J, Richards GK. The activity of rifampin and analogs against Staphylococcus epidermidis biofilms in ACAPD environment model. Am. J. Nephrol. 1989; 9: 414-20.
21. Van Wijngaerden E, Peetermans WE, Vandersmissen J, Van Lierde S, Bobbaers H, Van Eldere J. Foreign body infection: a new rat model for prophylaxis and treatment. J. Antimicrob. Chemother. 1999; 44: 669-74.
22. Agalar C, Eroglu E, Sari M, Sari A, Daphan C, Agalar F. The effect of G-CSF in an experimental MRSA graft infection in mice. J. Invest. Surg. 2005; 18: 227-31.
23. Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N. Engl. J. Med. 1992; 326: 281-6.